Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer.

Abstract

In contrast to the amazing exponential growth in knowledge related to long non-coding RNAs (lncRNAs) involved in cell homeostasis or dysregulated pathological states, little is known so far about the links between the chemical modifications occurring in lncRNAs and their function. Generally, ncRNAs are post-transcriptional regulators of gene expression, but RNA modifications occurring in lncRNAs generate an additional layer of gene expression control. Chemical modifications that have been reported in correlation with lncRNAs include m⁶A, m⁵C and pseudouridylation. Up to date, several chemically modified long non-coding transcripts have been identified and associated with different pathologies, including cancers. This review presents the current level of knowledge on the most studied cancer-related lncRNAs, such as the metastasis associated lung adenocarcinoma transcript 1 (MALAT1), the Hox transcript antisense intergenic RNA (HOTAIR), or the X-inactive specific transcript (XIST), as well as more recently discovered forms, and their potential roles in different types of cancer. Understanding how these RNA modifications occur, and the correlation between lncRNA changes in structure and function, may open up new therapeutic possibilities in cancer.

• Authors: Sorina Dinescu, Simona Ignat, Andreea Daniela Lazar, Carolina Constantin, Monica Neagu, Marieta Costache
• Journal: Genes (Genes (Basel)) Vol. 10 Issue 1 (01 16 2019) ISSN: 2073-4425 [Print] Switzerland
• PMID: 30654440 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• RNA, Long Noncoding

Topics

• Epigenesis, Genetic
• Humans
• Neoplasms (genetics)
• RNA, Long Noncoding (genetics)
• Transcriptome